(1 - 9 von 15
)
EQS-News: Formycon and Fresenius Kabi conclude global ...Bloomberg
www.bloomberg.com
— ... worldwide,” says Dr. Michael Schönhofen, Fresenius Kabi's Chief Operating Officer and Member of the Fresenius Kabi Management Board.
Fresenius Kabi Receives U.S. FDA Approval for Biosimilar ...AP News
apnews.com
— Dr. Michael Schönhofen, Fresenius Kabi's Chief Operating Officer and Member of the Fresenius Kabi Management Board, said: “The FDA approval ...
sortiert nach Relevanz / Datum